Mirum Pharmaceuticals, Inc. MIRM Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share?
- Mirum Pharmaceuticals, Inc. (MIRM) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.